Management of hot flushes due to endocrine therapy for prostate carcinoma

ONCOLOGY

Volumn 10, Issue 9, 1996, Pages 1319-1322

  Smith Jr , Joseph A ^a   Bray, William L ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; BICALUTAMIDE; CLONIDINE; CYPROTERONE ACETATE; DIETHYLSTILBESTROL; ERGOTAMINE; ESTROGEN; FLUTAMIDE; GONADORELIN DERIVATIVE; GOSERELIN; LEUPRORELIN; MEGESTROL ACETATE; NILUTAMIDE; PHENOBARBITAL;

GYNECOMASTIA; HOT FLUSH; HUMAN; MALE; PROSTATE CARCINOMA; SHORT SURVEY;

ANTINEOPLASTIC AGENTS, HORMONAL; DIETHYLSTILBESTROL; ESTROGENS, NON-STEROIDAL; FLUSHING; GYNECOMASTIA; HUMANS; MALE; ORCHIECTOMY; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE;

EID: 0029780846     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (22)

1. Huggins C, Hodges GV: Studies on prostate cancer: I. The effect of castration, estrogen and androgen injections on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1:293-295, 1941.
2. McCallum KA, Reading C: Hot flushes are induced by thermogenic stimuli. Br J Urol 64:507, 1989.
3. Gambone J, Meldram DR, Laufer L, et al: Further delineation of hypothalamic dysfunction responsible for menopausal hot flushes. J Clin Endocrinol Metab 59:1097, 1984.
4. Casper RF, Yen SSC: Neuroendocrinology of menopausal flushes: An hypothesis of the flush mechanism. Clin Endocrinol 22:293, 1985.
5. Terasawa E, Krook C, Hei DL, et al: Norepinephrine is a possible neurotransmitter stimulating pulsatile release of luteinizing hormone-releasing hormone in the rhesus monkey. Endocrinology 123:1808, 1988.
6. Radlmaier A, Bormacher K, Neumann F: Hot flushes: Mechanism and prevention. Prog Clin Biol Res 359:131, 1990
7. Maatman TJ, Gupta MK, Montie JE: Effectiveness of castration versus intravenous estrogen therapy in producing rapid endocrine control of metastatic cancer of the prostate. J Urol 133:620-621, 1985.
8. Charig CR, Rundle, JS: Flushing: Long term side effect of orchiectomy in treatment of prostatic carcinoma. Urology 33:175, 1989
9. Robinson MRG, Thomas BS: Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma Br Med J 4:391-394, 1971.
10. Smith JA Jr: Endocrine treatment, in Smith JA Jr, Middleton RG (eds): Clinical Management of Prostate Cancer, pp 134-153. Chicago, Year Book Medical Publishers, 1987.
11. Smith JA Sr: New methods of endocrine management of prostate cancer. J Urol 137:1-10, 1987.
12. Dubruyne FMJ: Long-term therapy with depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinoma. J Urol 140:775-777, 1988.
13. The Leuprolide Study Group: Leuprolide versus diethylstilbestrol for metastatic prostate cancer. N Engl J Med 311:1281, 1989.
14. Crawford ED, Eisenberger MA, McLeod DG, et al: A controlled trial of Leuprolide with and without flutamide in prostatic cancer. N Engl J Med 321:419-424, 1989.
15. Janknegt RA, the Anandron International Study Group: Total androgen blockade with the use of orchiectomy and nilutamide (Anandron) or placebo as treatment of metastatic prostate cancer. Cancer 72:3874-3877, 1993.
16. Denis L, Smith P, Carneiro de Moura JL, et al: Total androgen ablation: European experience. Urol Clin North Am 18:65-73, 1992.
17. Eaton AC, McGuire N: Cyproterone acetate in treatment of post-orchidectomy hot flushes: Double-blind cross-over trial. Lancet 2:1336, 1983.
18. Atala A, Amin, Harty JI: Diethylstilbestrol in treatment of postorchiectomy vasomotor symptoms and its relationship with serum follicle-stimulating hormone, luteinizing hormone and testosterone. Urology 34:108, 1992.
19. Miller JI, Ahmann FR: Treatment of castration-induced menopausal symptoms with low dose diethylstilbestrol in men with advanced prostate cancer. Urology 40:499, 1992.
20. Clayden JR, Bell JW, Pollard P: Menopausal flushing: Double-blind trial of a non- hormonal medication. Br Med J 1:409, 1974.
21. Smith JA Jr: A prospective comparison of treatments for symptomatic hot flushes following endocrine therapy for carcinoma of the prostate. J Urol 152:132-134, 1994.
22. Loprinzi CL, Michalak JC, Quella SK, et al: Megestrol acetate for the prevention of hot flushes. N Engl J Med 331:347-352, 1994.